Tubulin protein (97% pure): porcine brain

Tubulin protein (97% pure): porcine brain

Product Uses Include

  • Economical alternative to T240 in primary screens for tubulin ligand drugs
  • High-throughput tubulin polymerization or depolymerization screens
  • Production of microtubule substrates for HTS motor assays

Tubulin protein has been isolated from porcine brain. The final product contains approximately 97% tubulin and 3% Microtubule Associated Proteins (MAPs). This version of porcine tubulin is an economical alternative to our highly purified tubulin (Cat. # T240) for anti-tubulin ligand drug discovery. It has been formulated to be compatible with 96 or 384-well format polymerization assays such as in Biochem™ kits BK004P or BK011P .

Protein purity is determined by scanning densitometry of Coomassie Blue stained protein on a 12% SDS-PAGE gel. HTS02 contains 97% tubulin (MW. 55 kDa) and 3% MAPs (MW 35-280 kDa).


Figure 1: A 100 µg sample of HTS03 protein was separated by electrophoresis on a 12% SDS-PAGE gel and stained with Coomassie Blue. Protein quantitation was performed using the Precision Red Protein Assay Reagent (Cat.# ADV02).

Biological Activity
An ASSAY UNIT is defined as the amount of HTS03 protein needed to achieve a tubulin polymerization signal of OD340 of 0.1 - 0.15 in 30 minutes at 37°C in G-PEM buffer. The assay volume is 100 µl and assumes a spectrophotometer pathlength of 0.5 cm. The protein concentration for HTS02 in this assay is approximately 4 mg/ml. The biological activity of HTS03 is assessed by a tubulin polymerization assay. One ASSAY UNIT of tubulin is used for each polymeriztion assay. An OD340 of 0.10 - 0.15 is required to pass quality control. Tubulin polymerization must also be responsive to polymerization enhancers (paclitaxel) and inhibitors (nocodazole) at 5 µM drug concentration.


Figure 2: Tubulin polymerization in a 96-well format using HTS03. All samples are in duplicates. Each well has a mini-polymerization curve with 20 min on the x-axis and 0.30 OD 340 nm on the y-axis. The Vmax parameter is used to compare inhibitors, the CV is 13% in this format, so a 50% cut off is required for a 98% confidence.

For product Datasheets and MSDSs please click on the PDF links below.   For additional information, click on the FAQs tab above or contact our Technical Support department at tservice@cytoskeleton.com

AuthorTitleJournalYearArticle Link
Tjioe, Marco et al.Multiple kinesins induce tension for smooth cargo transporteLife2019ISSN 2050-084X
Chen, Yang et al.Visualizing Autophagic Lysosome Reformation in Cells Using In Vitro Reconstitution SystemsCurrent Protocols in Cell Biology2018ISSN 1934-2616
Qi, Jianguo et al.Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitorsEuropean Journal of Medicinal Chemistry2018ISSN 1768-3254
Khatra, Harleen et al.Hedgehog Antagonist Pyrimidine–Indole Hybrid Molecule Inhibits Ciliogenesis through Microtubule DestabilisationChemBioChem2018ISSN 1439-7633
Su, Qian Peter et al.Corrigendum: Vesicle Size Regulates Nanotube Formation in the CellScientific reports2017ISSN 2045-2322
Zhang, Rui et al.Interplay of structure, elasticity, and dynamics in actin-based nematic materialsProceedings of the National Academy of Sciences of the United States of America2017ISSN 1091-6490
Francis, Joshua W. et al.A trimer consisting of the Tubulin-specific Chaperone D (TBCD), regulatory GTPase ARL2, and β-tubulin is required for maintaining the microtubule networkJournal of Biological Chemistry2017ISSN 1083-351X
Du, Wanqing et al.Kinesin 1 Drives Autolysosome TubulationDevelopmental Cell2016ISSN 1878-1551
Magalhaes, Luma G. et al.Discovery of a series of acridinones as mechanism-based tubulin assembly inhibitors with anticancer activityPLoS ONE2016ISSN 1932-6203
Wang, Chong et al.Dynamic tubulation of mitochondria drives mitochondrial network formationCell Research2015ISSN 1748-7838
Talà, Adelfia et al.Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerizationInfection and Immunity2014ISSN 0019-9567
Li, Chien Ming et al.Orally Bioavailable Tubulin Antagonists for Paclitaxel-Refractory CancerPharmaceutical Research 2012 29:112012ISSN 1573--904X
Samson, Andre L. et al.Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by PlasminCell Reports2012ISSN 2211-1247
Sackett, Dan L. et al.Intracellular proadrenomedullin-derived peptides decorate the microtubules and contribute to cytoskeleton functionEndocrinology2008ISSN 0013-7227


Question 1:  Does tubulin polymerization using 97% pure porcine brain tubulin (Cat. # HTS03) require additional enhancers such as glycerol or taxol?

Answer 1:  No additional enhancers are required when using 3 or 4 mg/ml of the MAP-enriched 97% pure tubulin.  The recommended polymerization reaction using 97% pure tubulin contains 100 μl of 3 or 4 mg/ml tubulin in 80 mM PIPES pH 6.9, 0.5 mM EGTA, 2 mM MgCl2 and 1 mM GTP.  Polymerization is started by incubation at 37°C and followed by absorption readings at 340 nm. Under these conditions, polymerization will reach a maximal OD340 between 0.15 – 0.25 within 30 minutes. In this experimental set up (100 μl volume in a spectrophotometer with a pathlength of 0.5 cm), an OD340 of 0.1 is approximately equal to 1 mg per ml of tubulin polymer mass.  Under these conditions only 40% of the tubulin is polymerized, offering the flexibity to study how polymerization enhancers (e.g., taxol) or inhibitors (e.g., nocodazole) alter tubulin polymerization.  For enhancers, we recommend using 3 mg/ml tubulin whereas for inhibitors, 4 mg/ml tubulin works better.


Question 2:  Upon resuspension as directed, what are the components of the final buffer?

Answer 2:  Upon reconstitution as directed, the tubulin will be in the following buffer: 80 mM PIPES, 1 mM EGTA, 1 mM MgCl2, pH 7.0, 1 mM GTP, 1% Ficoll, 5% sucrose and <1mM DTT.



If you have any questions concerning this product, please contact our Technical Service department at tservice@cytoskeleton.com